ReadingResearchRadarInvestment frameworkAI Company Primary Sources
Sign in / Sign up
← Back to reading
NewsMaterial3 min readDisconfirmAI Editorial

OpenAI's Head of Health AI: Medical Intelligence Costs Are Collapsing, But Savings Come from Workflow Integration, Not the Model Itself

Karan Singhal, OpenAI’s head of health AI research, outlined the core logic of the company’s healthcare strategy in a podcast with Andreessen Horowitz (a16z): health intelligence should be embedded within general-purpose frontier models rather than standalone medical ones. The latest model costs are 34 times lower than the previous month’s flagship, but Singhal argues that compressing the United States’ $5.3 trillion healthcare expenditure will not come from intelligence itself, but from workflow integration. He explicitly draws a boundary—OpenAI acts as the “front door” and “quarterback,” not a care provider. For investors, this signals that the value source for healthcare AI is shifting from model capability to workflow ownership.

2026-10-20 18:00 GMT+8

Karan Singhal, OpenAI’s head of health AI research, explained the underlying logic of the company’s healthcare strategy to partner Jay Rughani on the a16z podcast. This logic rests on an counterintuitive core judgment: the cost-saving mechanism of healthcare AI does not lie in models becoming smarter, but in workflows being redesigned.

Singhal provided specific cost evidence. He stated that GPT-6 Luna is OpenAI’s cheapest frontier model on its API, scoring higher on HealthBench Professional than GPT-5.6 Sol—the latter was the company’s best model just a month ago—while costing only one-thirty-fourth of the latter’s price. He expects the cost of a fixed level of health intelligence to continue plummeting, while the trust threshold continues to rise.

But Singhal immediately made an uncommonly honest cut in the industry. He said, 'I don’t think health intelligence has yet had a macro effect on the problem you’re describing.' US healthcare spending exceeds $5.3 trillion, and ChatGPT has over 300 million weekly users asking health questions, but Singhal clearly pointed out that abundant health intelligence is merely a prerequisite for compressing expenditures, not a sufficient condition; true compression comes from integration, workflows, deployment, and scaling.

Sign in / Sign up
ReadingResearchRadarInvestment frameworkAI Company Primary Sources

What does this distinction mean for investors? If a single model’s cost can drop to one-thirty-fourth of the flagship within a month, then companies owning the smartest models do not automatically capture value from healthcare spending. Value capture occurs where intelligence is embedded into workflows, where deployment paths are designed, and where compliance and integration frictions are resolved. Singhal himself provided a concrete example: health system AdventHealth reported approximately an 80% reduction in administrative workflow costs after deploying AI agents, a result driven by workflow redesign, not by a better model.

In terms of strategic positioning, Singhal repeatedly emphasized a boundary: medical information and medical care are not the same business. He said, 'There is no future where any one company delivers all medical care,' defining OpenAI’s role as the 'front door' and 'quarterback'—navigating, dispatching, marking when medical attention is needed—while leaving actual care to partners. He explicitly ruled out OpenAI managing chronic conditions itself.

Regarding why OpenAI chose general-purpose models over standalone medical models, Singhal explained that general capabilities are advancing too quickly; a forked, smaller specialized model would be overtaken before it could be properly maintained. His solution is to inject physician-sourced healthcare data into every stage of training for every general-purpose model, allowing the same model to write code, plan vacations, and answer medical questions, with behavior adjusted based on the questioner. He calls this 'the best of both worlds'—frontier-scale reasoning combined with medical grounding.

For builders and investors in the healthcare AI space, Singhal’s advice is a clear bet: 'I would say bet on models getting better—that is probably the most important thing.' He observed that people in the healthcare industry are distributed across a spectrum, from betting against models improving, to neutral, to betting on models getting better. His stance is the latter.

But this line contains an unresolved tension. OpenAI possesses the entry point of 300 million weekly health users, a collapsing cost curve, and evaluation infrastructure like HealthBench, yet it repeatedly excludes itself from delivering care. This means realizing potential savings from the $5.3 trillion depends on partners and workflow integration that OpenAI does not control, as well as a trust threshold that Singhal describes as approaching but not yet reached.

a16z disclosed in the show notes that its affiliates may hold investments in the companies discussed. All of Singhal’s numbers and judgments are statements he made personally on the podcast and have not been independently verified.

Sources

  • a16z.simplecast.com↗
  • podcasts.apple.comApple Podcasts↗
  • finance.biggo.comBigGo Finance↗
Continue researching →